Arleth Tobias, Baekgaard Josefine, Siersma Volkert, Creutzburg Andreas, Dinesen Felicia, Rosenkrantz Oscar, Heiberg Johan, Isbye Dan, Mikkelsen Søren, Hansen Peter M, Zwisler Stine T, Darling Søren, Petersen Louise B, Mørkeberg Maria C R, Andersen Mikkel, Fenger-Eriksen Christian, Bach Peder T, Van Vledder Mark G, Van Lieshout Esther M M, Ottenhof Niki A, Maissan Iscander M, Den Hartog Dennis, Hautz Wolf E, Jakob Dominik A, Iten Manuela, Haenggi Matthias, Albrecht Roland, Hinkelbein Jochen, Klimek Markus, Rasmussen Lars S, Steinmetz Jacob
Department of Anesthesia, Center of Head and Orthopedics, Rigshospitalet, Copenhagen, Denmark.
The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
JAMA. 2025 Feb 11;333(6):479-489. doi: 10.1001/jama.2024.25786.
Early administration of supplemental oxygen for all severely injured trauma patients is recommended, but liberal oxygen treatment has been associated with increased risk of death and respiratory complications.
To determine whether an early 8-hour restrictive oxygen strategy compared with a liberal oxygen strategy in adult trauma patients would reduce death and/or major respiratory complications.
DESIGN, SETTING, AND PARTICIPANTS: This randomized controlled trial enrolled adult trauma patients transferred directly to hospitals, triggering a full trauma team activation with an anticipated hospital stay of a minimum of 24 hours from December 7, 2021, to September 12, 2023. This multicenter trial was conducted at 15 prehospital bases and 5 major trauma centers in Denmark, the Netherlands, and Switzerland. The 30-day follow-up period ended on October 12, 2023. The primary outcome was assessed by medical specialists in anesthesia and intensive care medicine blinded to the randomization.
In the prehospital setting or on trauma center admission, patients were randomly assigned 1:1 to a restrictive oxygen strategy (arterial oxygen saturation target of 94%) (n = 733) or liberal oxygen strategy (12-15 L of oxygen per minute or fraction of inspired oxygen of 0.6-1.0) (n = 724) for 8 hours.
The primary outcome was a composite of death and/or major respiratory complications within 30 days. The 2 key secondary outcomes, death and major respiratory complications within 30 days, were assessed individually.
Among 1979 randomized patients, 1508 completed the trial (median [IQR] age, 50 [31-65] years; 73% male; and median Injury Severity Score was 14 [9-22]). Death and/or major respiratory complications within 30 days occurred in 118 of 733 patients (16.1%) in the restrictive oxygen group and 121 of 724 patients (16.7%) in the liberal oxygen group (odds ratio, 1.01 [95% CI, 0.75 to 1.37]; P = .94; absolute difference, 0.56 percentage points [95% CI, -2.70 to 3.82]). No significant differences were found between groups for each component of the composite outcome. Adverse and serious adverse events were similar across groups, with the exception of atelectasis, which was less common in the restrictive oxygen group compared with the liberal oxygen group (27.6% vs 34.7%, respectively).
In adult trauma patients, an early restrictive oxygen strategy compared with a liberal oxygen strategy initiated in the prehospital setting or on trauma center admission for 8 hours did not significantly reduce death and/or major respiratory complications within 30 days.
ClinicalTrials.gov Identifier: NCT05146700.
建议对所有重伤创伤患者尽早给予补充氧气,但自由氧疗与死亡风险和呼吸并发症增加有关。
确定在成年创伤患者中,与自由氧策略相比,早期8小时限制性氧策略是否能降低死亡和/或主要呼吸并发症的发生率。
设计、地点和参与者:这项随机对照试验纳入了直接转至医院的成年创伤患者,自2021年12月7日至2023年9月12日,触发了全面创伤团队启动,预计住院时间至少24小时。这项多中心试验在丹麦、荷兰和瑞士的15个院前基地和5个主要创伤中心进行。30天随访期于2023年10月12日结束。主要结局由对随机分组不知情的麻醉和重症医学专家评估。
在院前环境或创伤中心入院时,患者按1:1随机分配至限制性氧策略组(动脉血氧饱和度目标为94%)(n = 733)或自由氧策略组(每分钟12 - 15升氧气或吸入氧分数为0.6 - 1.0)(n = 724),为期8小时。
主要结局为30天内死亡和/或主要呼吸并发症的复合结局。对2个关键次要结局,即30天内死亡和主要呼吸并发症分别进行评估。
在1979例随机分组的患者中,1508例完成试验(年龄中位数[四分位间距]为50[31 - 65]岁;73%为男性;损伤严重程度评分中位数为14[9 - 22])。限制性氧组733例患者中有118例(16.1%)在30天内发生死亡和/或主要呼吸并发症,自由氧组724例患者中有121例(16.7%)发生(比值比,1.01[95%置信区间,0.75至1.37];P = 0.94;绝对差异,0.56个百分点[95%置信区间,-2.70至3.82])。复合结局的各组成部分在组间未发现显著差异。除肺不张外,各组不良和严重不良事件相似,与自由氧组相比,限制性氧组肺不张较少见(分别为27.6%和34.7%)。
在成年创伤患者中,与在院前环境或创伤中心入院时启动的自由氧策略相比,早期8小时限制性氧策略在30天内并未显著降低死亡和/或主要呼吸并发症的发生率。
ClinicalTrials.gov标识符:NCT05146700。